| 6752 | N | 208910 | 002 | VANCOMYCIN HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | FIRVANQ KIT | AZURITY | EQ 50MG BASE/ML | | [] | 2018-01-26 | Jan 26, 2018 | No | Yes | Yes | RX | AZURITY PHARMACEUTICALS INC | f73a793ff578aaf3e35bf90e349f6628c4542fdc965a3cfae251ea1769e8e440 |
| 6753 | A | 212548 | 001 | FOSFOMYCIN TROMETHAMINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | FOSFOMYCIN TROMETHAMINE | XIROMED | EQ 3GM BASE/PACKET | AA | ["AA"] | 2020-10-06 | Oct 6, 2020 | No | No | No | RX | XIROMED PHARMA ESPANA SL | 64f3d4fccef23762b7d84dc9bb9a5ad0e7b908b3297fcd851720c5dab736a03a |
| 6754 | N | 208630 | 001 | AMINOLEVULINIC ACID HYDROCHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | GLEOLAN | NXDC | 1.5GM/VIAL | | [] | 2017-06-06 | Jun 6, 2017 | No | Yes | Yes | RX | NX DEVELOPMENT CORP | c3c5bbc44d021280d4085871624fff72ecb2a0304eea5195e05af055c7a8fce2 |
| 6755 | A | 076652 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | GLYCOLAX | LANNETT CO INC | 17GM/SCOOPFUL | | [] | 2004-07-02 | Jul 2, 2004 | No | No | No | DISCN | LANNETT CO INC | 368c553a6d491c9dd0ddd346c27d287099e0c4a188f22a709c4fce390ad0f17c |
| 6756 | A | 090600 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | GLYCOLAX | LANNETT CO INC | 17GM/PACKET | | [] | 2009-10-06 | Oct 6, 2009 | No | No | No | OTC | LANNETT CO INC | fa866a30007b1314a0a5625aa3eead291161864682250e30bc757640a70ff604 |
| 6757 | A | 090600 | 002 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | GLYCOLAX | LANNETT CO INC | 17GM/SCOOPFUL | | [] | 2009-10-06 | Oct 6, 2009 | No | No | No | OTC | LANNETT CO INC | b34b735d75a49f4b16b55620edc8f0078bd8c5d2c068be5ae28caa1b97c3f667 |
| 6758 | N | 019011 | 002 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | GOLYTELY | BRAINTREE | 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PACKET;5.53GM/PACKET;21.5GM/PACKET | | [] | 1992-06-02 | Jun 2, 1992 | No | Yes | No | DISCN | BRAINTREE LABORATORIES INC | 87e1d15fcda73d3303bc5f6657e2189d39ff2867f4ba81f3d3e81e0caf953009 |
| 6759 | N | 019011 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | GOLYTELY | BRAINTREE | 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT | AA | ["AA"] | 1984-07-13 | Jul 13, 1984 | No | Yes | Yes | RX | BRAINTREE LABORATORIES INC | df9765ce9ec3ebbb335e4448ef588b71440d76f9f18f7702fd6245cf42198566 |
| 6760 | N | 021092 | 001 | UREA C-13 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | HELICOSOL | METABOLIC SOLUTIONS | 125MG/VIAL | | [] | 1999-12-17 | Dec 17, 1999 | No | No | No | DISCN | METABOLIC SOLUTIONS INC | d3090c8bfefd898216710ced19a89260fbf3f89e19c7d8015619be6f8476b131 |
| 6761 | A | 209662 | 001 | POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | KLOR-CON | UPSHER SMITH LABS | 20MEQ | AA | ["AA"] | 2017-10-23 | Oct 23, 2017 | No | No | No | RX | UPSHER SMITH LABORATORIES LLC | 70258d53738c95257a1e6b25765d4891be7cc9a7111d659691677df183e2ff46 |
| 6762 | A | 074712 | 001 | LACTULOSE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | LACTULOSE | CUMBERLAND PHARMS | 10GM/PACKET | | [] | 1997-12-10 | Dec 10, 1997 | No | No | Yes | RX | CUMBERLAND PHARMACEUTICALS INC | afb0e39cd51b3d3b4b96516d5ba8ef7a71c4fcbdca91ad55633afdf624ea2423 |
| 6763 | A | 074712 | 002 | LACTULOSE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | LACTULOSE | CUMBERLAND PHARMS | 20GM/PACKET | | [] | 1997-12-10 | Dec 10, 1997 | No | No | Yes | RX | CUMBERLAND PHARMACEUTICALS INC | 0f9168b21e62b5e8d67369a6d42df3f22b619d342053e018238ecec6aaabd654 |
| 6764 | A | 079232 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | LAX-LYTE WITH FLAVOR PACKS | PADDOCK LLC | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | AA | ["AA"] | 2010-02-25 | Feb 25, 2010 | No | No | No | RX | PADDOCK LABORATORIES LLC | 480a3a64251315140f8d9ec4a6b6f7e07fcae337172ea7de8f8744b208ac082c |
| 6765 | A | 060136 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | LEDERCILLIN VK | LEDERLE | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO | acbd0c21fba803f4a9304122c0fd998bd2793a67cf1c2686c035eed11767a615 |
| 6766 | A | 060136 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | LEDERCILLIN VK | LEDERLE | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO | cfc94888b0af25c78936e6ea3923307c1a71d0c548a6ee149027469265860117 |
| 6767 | N | 008107 | 003 | LEUCOVORIN CALCIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | LEUCOVORIN CALCIUM | HOSPIRA | EQ 60MG BASE/VIAL | | [] | 1987-01-30 | Jan 30, 1987 | No | No | No | DISCN | HOSPIRA INC | 11edcd1a8c04a96dacdc26f73cf56eaba8593707a9607f1fa0427f8300809abf |
| 6768 | N | 020686 | 001 | MANGANESE CHLORIDE TETRAHYDRATE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | LUMENHANCE | BRACCO | 3.49MG/GM | | [] | 1997-12-19 | Dec 19, 1997 | No | No | No | DISCN | BRACCO DIAGNOSTICS INC | 1c2b435736e675377ccdccd82d20ee3e0a4c0e03968491ce071991c40b823c98 |
| 6769 | N | 205598 | 001 | MACIMORELIN ACETATE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | MACRILEN | NOVO | EQ 60MG BASE/POUCH | | [] | 2017-12-20 | Dec 20, 2017 | No | Yes | Yes | RX | NOVO NORDISK INC | 3908f92051409997c969dd6946fac9024b717daff977a0121c7928405a3c5a6a |
| 6770 | N | 020586 | 001 | UREA C-13 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | MERETEK UBT KIT (W/ PRANACTIN) | OTSUKA AMERICA | 125MG/VIAL | | [] | 1996-09-17 | Sep 17, 1996 | No | No | No | DISCN | OTSUKA AMERICA PHARMACEUTICALS INC | bdd4a726af69506bd672093ba61f02b60d34be01a507ac6c8b21ac309d183d97 |
| 6771 | N | 022015 | 001 | POLYETHYLENE GLYCOL 3350 | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | MIRALAX | BAYER HEALTHCARE LLC | 17GM/SCOOPFUL | | [] | 2006-10-06 | Oct 6, 2006 | No | Yes | Yes | OTC | BAYER HEALTHCARE LLC | db019c9d262f1c5b361f0bd9a53ac2eb2264207c69278c3f5b4b93c3b578bdc0 |
| 6772 | N | 050717 | 001 | FOSFOMYCIN TROMETHAMINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | MONUROL | ZAMBON SPA | EQ 3GM BASE/PACKET | AA | ["AA"] | 1996-12-19 | Dec 19, 1996 | No | Yes | Yes | RX | ZAMBON SPA ITALY | fe237b291d94e1736bdea183651a1356c042b95a1fab7cef207c476cac39941f |
| 6773 | N | 021881 | 001 | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | MOVIPREP | SALIX PHARMS | 4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM | AA | ["AA"] | 2006-08-02 | Aug 2, 2006 | No | Yes | Yes | RX | SALIX PHARMACEUTICALS INC | 20e1b31a567fbce2c1462211e23b374222d88e5cf8f391665c433a506b58efc4 |
| 6774 | N | 019797 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | NULYTELY | BRAINTREE | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | AA | ["AA"] | 1991-04-22 | Apr 22, 1991 | No | Yes | Yes | RX | BRAINTREE LABORATORIES INC | ff3d3a2977aa3915cff3d8c5cb88a699a4fd7ae58cd9dafe940799cb8d36b167 |
| 6775 | N | 019797 | 002 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | NULYTELY-FLAVORED | BRAINTREE | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | AA | ["AA"] | 1994-11-18 | Nov 18, 1994 | No | Yes | Yes | RX | BRAINTREE LABORATORIES INC | 403014a59ee6e7645280656dd1574d9b179a7a334a9314cd3eb0cbb289f100ed |
| 6776 | N | 021667 | 001 | L-GLUTAMINE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | NUTRESTORE | EMMAUS MEDCL | 5GM/PACKET | | [] | 2004-06-10 | Jun 10, 2004 | No | Yes | No | DISCN | EMMAUS MEDICAL INC | a148fce882ee7755b973d6b1038b73ab47db8bc7027423855d7e80108d178643 |
| 6777 | N | 205383 | 001 | IOHEXOL | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | ORALTAG | INTERPHARMA PRAHA AS | 9.7GM/BOT | | [] | 2015-03-26 | Mar 26, 2015 | No | No | No | RX | INTERPHARMA PRAHA AS | 66b0f8adf1547cff3f3d3ee191fa45aad0ed6eeac7fcba505594ae8f332ca1c6 |
| 6778 | A | 061457 | 001 | OXACILLIN SODIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | OXACILLIN SODIUM | APOTHECON | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 3ff2cd6126fd26f4025b918c9ac1f4c355f99b12eed52378442d98193a3b262b |
| 6779 | A | 062252 | 001 | OXACILLIN SODIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | OXACILLIN SODIUM | TEVA | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | 50db5a3f1b681cd430b26edc2cc865783acdfdc02ea8855b24079d70fc29f8f2 |
| 6780 | A | 090928 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEG 3350 AND ELECTROLYTES | MYLAN | 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT | | [] | 2010-01-28 | Jan 28, 2010 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | d6bb4ecc64e1649c9e9dc750ff505d94ea812c083dd4b70923d99603a8b13a2f |
| 6781 | A | 090231 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEG 3350 AND ELECTROLYTES | NOVEL LABS INC | 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT | AA | ["AA"] | 2009-06-01 | Jun 1, 2009 | No | No | No | RX | NOVEL LABORATORIES INC | fafee751c0290f246ed0066eaab9f3018ec1ecfa07cf5140228240593efdda49 |
| 6782 | A | 090186 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEG 3350 AND ELECTROLYTES | NOVEL LABS INC | 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/BOT;22.72GM/BOT | AA | ["AA"] | 2009-06-01 | Jun 1, 2009 | No | No | No | RX | NOVEL LABORATORIES INC | c07ceffeb01e322c503dea2af26226995e0623eb9c6b865ec7c8e9a306dda554 |
| 6783 | A | 090409 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE | MYLAN | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | | [] | 2010-04-02 | Apr 2, 2010 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | c922a3deb295b7103047410e3decbd3d5a965dc18ef6cecb1a54fdf7453b0415 |
| 6784 | A | 202060 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE | NOSTRUM LABS INC | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | | [] | 2017-03-08 | Mar 8, 2017 | No | No | No | DISCN | NOSTRUM LABORATORIES INC | 743c89d4d44b5b72c4f99ebd3af702667e9e234d7558f0b7544141f8deb40a13 |
| 6785 | A | 090019 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE | NOVEL LABS INC | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | AA | ["AA"] | 2009-05-27 | May 27, 2009 | No | No | No | RX | NOVEL LABORATORIES INC | f60c45ad5d665a8d50dfcf740c8f944637f1edbf98107b3e6e955759a25d4695 |
| 6786 | A | 204559 | 001 | POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE | STRIDES PHARMA | 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT | AA | ["AA"] | 2015-04-13 | Apr 13, 2015 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 2ca9f0b62cc6732906a1734d6c790c9fa0322db1eaa16d1b00ec02259a184612 |
| 6787 | A | 090145 | 001 | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID | NOVEL LABS INC | 4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM | AA | ["AA"] | 2012-01-25 | Jan 25, 2012 | No | No | No | RX | NOVEL LABORATORIES INC | 18bbba91640381219c8dc42588a172fad3461d265f95c543fca7c9368318800f |
| 6788 | A | 060007 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEN-VEE K | WYETH AYERST | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 56efe2ce797c514dbcc44bd97244b6147f9ff1f4480364eae9a91c98a303e850 |
| 6789 | A | 060007 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PEN-VEE K | WYETH AYERST | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 2dbf1d978955046d41cac16b6cbed30f9b898135a22db20fb8ea0b75e727f180 |
| 6790 | A | 062002 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENAPAR-VK | PARKE DAVIS | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PARKE DAVIS DIV WARNER LAMBERT CO | 104805f4a784c86ee6c4f46279566c68035944323e0b2ad482132cfceb2ae45f |
| 6791 | A | 062002 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENAPAR-VK | PARKE DAVIS | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PARKE DAVIS DIV WARNER LAMBERT CO | 45b15f9938dc41b396251b725c72ccb5941c8a86442b9342e9738688704b2226 |
| 6792 | A | 060307 | 002 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN | TEVA | 200,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | d4af876307a6254cedce791f8bcd6be0602a4c98b08a8c5de53d844a9e457480 |
| 6793 | A | 060307 | 004 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN | TEVA | 400,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | b69bbb9da52b2671e3f28a9d3118629c9ac00242d104e956221d62f9a726bc09 |
| 6794 | A | 060752 | 003 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN G POTASSIUM | MYLAN | 200,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | MYLAN PHARMACEUTICALS INC | a0e8b695ff43ef081e21d3e5d218d9635eeffa98919d354a2a9a1bc2c5794a83 |
| 6795 | A | 060752 | 002 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN G POTASSIUM | MYLAN | 250,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 5034eb43e796e43d6b335a9441b11aa11edc5e00ccd9c2fa32dd6600e5b656cd |
| 6796 | A | 060752 | 001 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN G POTASSIUM | MYLAN | 400,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 91921e1b4aa478fabb3b1510d1c1d3dba8d47ee91e137c8173f2512a623830cb |
| 6797 | A | 061740 | 001 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN G POTASSIUM | PUREPAC PHARM | 250,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PUREPAC PHARMACEUTICAL CO | fc9f8f07232c38bb280d7b266ff7a1313d74a95a43e57858d781315387f2d3ff |
| 6798 | A | 061740 | 002 | PENICILLIN G POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN G POTASSIUM | PUREPAC PHARM | 400,000 UNITS/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PUREPAC PHARMACEUTICAL CO | 6149672f62b4b61ea40284b1e640568bcad4a90e264fb7da680377a4027990fc |
| 6799 | A | 061529 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN V POTASSIUM | BELCHER PHARMS | EQ 125MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BELCHER PHARMACEUTICALS INC | 5aa61a425ce95b6b8abd1af3e9adebaf488c7850091cc8f4c223eca4aaa05424 |
| 6800 | A | 061529 | 002 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN V POTASSIUM | BELCHER PHARMS | EQ 250MG BASE/5ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | BELCHER PHARMACEUTICALS INC | 73ff9cd5fdadfddbbbc389cbdea8a06e689053306eb087a05bbddbc4612cc613 |
| 6801 | A | 062981 | 001 | PENICILLIN V POTASSIUM | FOR SOLUTION;ORAL | FOR SOLUTION | ORAL | PENICILLIN V POTASSIUM | DAVA PHARMS INC | EQ 125MG BASE/5ML | | [] | 1989-02-10 | Feb 10, 1989 | No | No | No | DISCN | DAVA PHARMACEUTICALS INC | 47bc5108266f5fa60b4b8da70dc387419a6a1a3ac0be76bdf1c0a6e201a1f811 |